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Abstract 
Gastric cancer is one of the most common cancers. Environmental factors, especially diet, play 
an important role in causing gastric cancer. The omega-3 (ω−3) and omega-6 (ω−6) from the 
polyunsaturated fatty acids (PUFAs) group as the natural compounds indicated significant 
effects on inhibiting various types of tumors. In this study, we investigated the anti-cancer 
properties of ω−3 and ω−6 on gastric cancer cells with focusing on WNT signaling pathway 
via WNT inhibitory Factor-1 (WIF-1) and The Wilms Tumor-1 (WT-1) genes. AGS cells were 
used to investigate the effects of ω−3 and ω−6 on cell viability, apoptosis and the expression 
of WIF-1 and WT-1 genes in gastric cancer. AGS cells were treated with different 
concentrations of ω−3 and ω−6 for 24, 48, and 72 h, and then cell viability was assessed by 
MTT assay. The apoptosis rate was assessed using the flow cytometery test in every three 
times. The mRNA expression of WIF-1 and WT-1 were examined by quantitative real-time 
PCR (qRT-PCR). Our study revealed that ω−3 and ω−6 provide various antitumor activities 
such as inhibition of cell viability in a dose and time-dependent manner. The results of flow 
cytometery showed that cytotoxicity effects are due to the ability of ω−3 and ω−6 to induce 
apoptosis. In addition, ω−3 and ω−6 significantly increased the expression of WIF-1, whereas 
WT-1 level decreased in AGS cells compared to the control group. These results suggested that 
ω−3 and ω−6 can serve as therapeutics in against gastric cancer by targeting of the WNT 
signaling pathway. 
 
